Global RNA Analysis & Transcriptomic Market Research Report 2023

Publication ID:

PB502243387

Publication Date:

February 9, 2023

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Retailing [2]

Consumer & Retail [3]

Description:

Highlights
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for RNA Analysis & Transcriptomic in Clinical Diagnostics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of RNA Analysis & Transcriptomic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific and Sequentia Biotech SL, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Analysis & Transcriptomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.
The RNA Analysis & Transcriptomic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global RNA Analysis & Transcriptomic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis & Transcriptomic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioM茅rieux SA
LC Sciences LLC
Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference
Segment by Application
Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis & Transcriptomic companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis & Transcriptomic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Toxicogenomics
1.3.5 Comparative Transcriptomics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis & Transcriptomic Market Perspective (2018-2029)
2.2 RNA Analysis & Transcriptomic Growth Trends by Region
2.2.1 Global RNA Analysis & Transcriptomic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA Analysis & Transcriptomic Historic Market Size by Region (2018-2023)
2.2.3 RNA Analysis & Transcriptomic Forecasted Market Size by Region (2024-2029)
2.3 RNA Analysis & Transcriptomic Market Dynamics
2.3.1 RNA Analysis & Transcriptomic Industry Trends
2.3.2 RNA Analysis & Transcriptomic Market Drivers
2.3.3 RNA Analysis & Transcriptomic Market Challenges
2.3.4 RNA Analysis & Transcriptomic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis & Transcriptomic Players by Revenue
3.1.1 Global Top RNA Analysis & Transcriptomic Players by Revenue (2018-2023)
3.1.2 Global RNA Analysis & Transcriptomic Revenue Market Share by Players (2018-2023)
3.2 Global RNA Analysis & Transcriptomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Analysis & Transcriptomic Revenue
3.4 Global RNA Analysis & Transcriptomic Market Concentration Ratio
3.4.1 Global RNA Analysis & Transcriptomic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis & Transcriptomic Revenue in 2022
3.5 RNA Analysis & Transcriptomic Key Players Head office and Area Served
3.6 Key Players RNA Analysis & Transcriptomic Product Solution and Service
3.7 Date of Enter into RNA Analysis & Transcriptomic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis & Transcriptomic Breakdown Data by Type
4.1 Global RNA Analysis & Transcriptomic Historic Market Size by Type (2018-2023)
4.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2024-2029)
5 RNA Analysis & Transcriptomic Breakdown Data by Application
5.1 Global RNA Analysis & Transcriptomic Historic Market Size by Application (2018-2023)
5.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America RNA Analysis & Transcriptomic Market Size (2018-2029)
6.2 North America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America RNA Analysis & Transcriptomic Market Size by Country (2018-2023)
6.4 North America RNA Analysis & Transcriptomic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis & Transcriptomic Market Size (2018-2029)
7.2 Europe RNA Analysis & Transcriptomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe RNA Analysis & Transcriptomic Market Size by Country (2018-2023)
7.4 Europe RNA Analysis & Transcriptomic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis & Transcriptomic Market Size (2018-2029)
8.2 Asia-Pacific RNA Analysis & Transcriptomic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2018-2023)
8.4 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis & Transcriptomic Market Size (2018-2029)
9.2 Latin America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America RNA Analysis & Transcriptomic Market Size by Country (2018-2023)
9.4 Latin America RNA Analysis & Transcriptomic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis & Transcriptomic Market Size (2018-2029)
10.2 Middle East & Africa RNA Analysis & Transcriptomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2018-2023)
10.4 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Detail
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Detail
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis & Transcriptomic Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Introduction
11.4.4 Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation RNA Analysis & Transcriptomic Introduction
11.6.4 Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.6.5 Danaher Corporation Recent Development
11.7 Fluidigm Corporation
11.7.1 Fluidigm Corporation Company Detail
11.7.2 Fluidigm Corporation Business Overview
11.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Introduction
11.7.4 Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.7.5 Fluidigm Corporation Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Introduction
11.8.4 Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.8.5 Eurofins Scientific Recent Development
11.9 Sequentia Biotech SL
11.9.1 Sequentia Biotech SL Company Detail
11.9.2 Sequentia Biotech SL Business Overview
11.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Introduction
11.9.4 Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.9.5 Sequentia Biotech SL Recent Development
11.10 Acobiom
11.10.1 Acobiom Company Detail
11.10.2 Acobiom Business Overview
11.10.3 Acobiom RNA Analysis & Transcriptomic Introduction
11.10.4 Acobiom Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.10.5 Acobiom Recent Development
11.11 GenXPro GmbH
11.11.1 GenXPro GmbH Company Detail
11.11.2 GenXPro GmbH Business Overview
11.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Introduction
11.11.4 GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.11.5 GenXPro GmbH Recent Development
11.12 CD Genomics
11.12.1 CD Genomics Company Detail
11.12.2 CD Genomics Business Overview
11.12.3 CD Genomics RNA Analysis & Transcriptomic Introduction
11.12.4 CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.12.5 CD Genomics Recent Development
11.13 Promega Corporation
11.13.1 Promega Corporation Company Detail
11.13.2 Promega Corporation Business Overview
11.13.3 Promega Corporation RNA Analysis & Transcriptomic Introduction
11.13.4 Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.13.5 Promega Corporation Recent Development
11.14 Cenix BioScience GmbH
11.14.1 Cenix BioScience GmbH Company Detail
11.14.2 Cenix BioScience GmbH Business Overview
11.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Introduction
11.14.4 Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.14.5 Cenix BioScience GmbH Recent Development
11.15 Takara Holdings, Inc.
11.15.1 Takara Holdings, Inc. Company Detail
11.15.2 Takara Holdings, Inc. Business Overview
11.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Introduction
11.15.4 Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.15.5 Takara Holdings, Inc. Recent Development
11.16 bioM茅rieux SA
11.16.1 bioM茅rieux SA Company Detail
11.16.2 bioM茅rieux SA Business Overview
11.16.3 bioM茅rieux SA RNA Analysis & Transcriptomic Introduction
11.16.4 bioM茅rieux SA Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.16.5 bioM茅rieux SA Recent Development
11.17 LC Sciences LLC
11.17.1 LC Sciences LLC Company Detail
11.17.2 LC Sciences LLC Business Overview
11.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Introduction
11.17.4 LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2018-2023)
11.17.5 LC Sciences LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioM茅rieux SA
LC Sciences LLC

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂